Dry Eye Syndrome

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dry Eye Syndrome Trial in United States (Low Dose - SkQ1, High dose - SkQ1, SkQ1 (Vehicle))

Completed
  • Dry Eye Syndrome
  • Low Dose - SkQ1
  • +2 more
  • Phoenix, Arizona
  • +6 more
Dec 20, 2021

Dry Eye Syndrome, Keratoconjunctivitis Sicca Trial in United States (0.05% Voclosporin Ophthalmic Solution (VOS), 0.10% VOS,

Completed
  • Dry Eye Syndrome
  • Keratoconjunctivitis Sicca
  • 0.05% Voclosporin Ophthalmic Solution (VOS)
  • +3 more
  • Newport Beach, California
  • +8 more
Dec 8, 2021

Dry Eye Syndrome Trial in United States (BRM421, Placebo)

Completed
  • Dry Eye Syndrome
  • Newport Beach, California
  • +3 more
Sep 24, 2021

Dry Eye Syndrome Trial in United States (TOP1630 0.1% Ophthalmic Solution TID OU, Placebo to TOP1630 0.1% Ophthalmic Solution

Completed
  • Dry Eye Syndrome
  • TOP1630 0.1% Ophthalmic Solution TID OU
  • Placebo to TOP1630 0.1% Ophthalmic Solution TID OU
  • Lewiston, Maine
  • +3 more
Aug 6, 2019

Dry Eye Syndrome Trial in United States (Reproxalap Ophthalmic Solution (0.25%), Reproxalap Ophthalmic Solution (0.1%), Vehicle

Completed
  • Dry Eye Syndrome
  • Reproxalap Ophthalmic Solution (0.25%)
  • +2 more
  • Waterbury, Connecticut
  • +5 more
Jul 10, 2019

Dry Eye Syndrome Trial in United States (Rebamipide 2% ophthalmic suspension, Placebo (vehicle))

Completed
  • Dry Eye Syndrome
  • Rebamipide 2% ophthalmic suspension
  • Placebo (vehicle)
  • Phoenix, Arizona
  • +33 more
Apr 17, 2014